Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about IPSEF

Recent news which mentions IPSEF

FDA Fast-Tracks Ipsen And Genfit's New Liver Disease Treatment, Iqirvo
Tickers GNFT IPSEF IPSEY NEWS
Tags News IPSEY GNFT
From Benzinga
Third Time Lucky: Exelixis' Cabozantinib Combo Therapy Aces Pivotal Study In Prostate Cancer Patients
Tickers EXEL IPSEF IPSEY RHHBF
Tags RHHBF General RHHVF
From Benzinga
What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's 'OCA In NASH May Never Occur
Tickers CBAY DRRX GNFT ICPT
Tags Market News Movers Briefs
From Benzinga
France-Based Ipsen Acquires Albireo Pharma Enriching Its Rare Disease Portfolio, Pipeline
Tickers ALBO IPSEF IPSEY
Tags why it's moving Biotech M&A
From Benzinga
Why Merrimack Shares Are Surging Over 200% Today?
Tickers IPSEF IPSEY MACK
Tags Briefs General Market News
From Benzinga
Merrimack Pharma-Ipsen's Cancer Drug Fails In Overall Survival Measure
Tickers IPSEF IPSEY MACK
Tags Benzinga Trading Ideas MACK
From Benzinga
Why Is Epizyme (EPZM) Stock Up 75% Today?
Tickers EPZM IPSEF
Tags NASDAQ:EPZM,OTCMKTS:IPSEF Today's Market Market News
From InvestorPlace
Ipsen Scoops Up Blood Cancer-Focused Epizyme - Read Why
Tickers EPZM IPSEF IPSEY
Tags General Briefs EPZM
From Benzinga
Ipsen - Exelixis' Cabometyx Scores European Approval As Second-Line Treatment For Thyroid Cancer
Tickers EXEL IPSEF IPSEY
Tags IPSEY News Biotech
From Benzinga
EMA's Scientific Committee Backs Expanded Use Of Exelixis, Ipsen's Cabometyx In Thyroid Cancer
Tickers EXEL IPSEF IPSEY
Tags Biotech News IPSEY
From Benzinga
Ipsen's Sohonos Scores Canadian Approval For Rare Connective Tissue Disease
Tickers IPSEF IPSEY
Tags Biotech IPSEY News
From Benzinga
Genfit Shares Rally After Ipsen Buys Rights To Its Late-Stage Kidney Disease Treatment Hopeful
Tickers GNFT IPSEF IPSEY
Tags Benzinga Trading Ideas Contracts
From Benzinga
Ipsen Stock Declines After Pulling Rare Disease Application
Tickers IPSEF IPSEY
Tags Movers Market News General
From Benzinga
Exicure Stock Surges On Over $1B Option Licensing Pact With Ipsen For Rare Neurodegenerative Disorders
Tickers IPSEF IPSEY XCUR
Tags Contracts Trading Ideas Benzinga
From Benzinga
Ipsen Beefs Up Pre-Clinical Oncology Pipeline With Over $850M Deal With BAKX Therapeutics
Tickers IPSEF IPSEY
Tags IPSEY News Biotech
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.